[6] Elias AD, Ibrahim J, Richardson P, et al. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program[J]. Biol Blood Marrow Tra lant, 2002, 8(4): 198-205.

[7] Bengala C, Pazzagli I, I ocenti F. et al. High-dose thiotepa and melphalan with hemopoietic progenitor su ort following induction therapy with epirubicin-paclitaxel-containing regime in metastatic breast cancer (MBC) [J]. A Oncol, 2001, Jan 12(1):69-74.

来源：ＣＳＣＯ论坛

上一页  [1] [2] [3] [4]